Brucella species comprise a group of Gram-negative bacteria known for causing brucellosis, a zoonotic infectious disease affecting both animals and humans. These bacteria, including species like B. abortus, B. melitensis, and B. suis, primarily infect domesticated animals such as cattle, goats, and pigs. Humans typically contract brucellosis through direct contact with infected animals or consumption of unpasteurized dairy products. Brucellosis manifests with a range of symptoms, including fever, fatigue, joint pain, and gastrointestinal issues. The chronic nature of the disease makes diagnosis challenging, and its impact on livestock poses economic concerns for agricultural communities. Prevention strategies involve vaccination of animals, pasteurization of dairy products, and adherence to proper hygiene practices during agricultural and veterinary activities. Efforts to control brucellosis also emphasize global cooperation and surveillance due to its potential as a bioterrorism agent. Enhanced biosecurity measures, research into new vaccines, and improved diagnostic tools are crucial components of a comprehensive approach to mitigate the impact of Brucella species on both animal and human health.
Title : Extensively drug-resistant bacterial infections: Confronting a global crisis with urgent solutions in prevention, surveillance, and treatment
Yazdan Mirzanejad, University of British Columbia, Canada
Title : Pathogen-derived noncanonical epitopes: Are they valuable targets for novel vaccinations and shall we be concerned about autoimmune responses?
Michele Mishto, Francis Crick Institute, United Kingdom
Title : Bioterrorism through the ages: Historical perspective, emerging threats, and medical countermeasures
Claudia Ferreira, Sorbonne University, France
Title : When acute EBV mimics HIV: A case of false positive p24 antigen and low-level HIV antibody reactivity
Smriti Chaudhary, Imperial College Healthcare NHS Trust, United Kingdom
Title : OnePeru: Peruvian bioinformatics platform to contribute to the fight against antimicrobial resistance
Pool Marcos Carbajal, University of San Martin de Porres, Peru
Title : Measles vaccination coverage indicators in 2023 and advance towards measles elimination and eradication by 2030
Pedro Plans Rubio, College of Physicians of Barcelona, Spain